Clinical Trial Update: Pilot Study of the Navigator Continuous Glucose Monitor [Phase 2, Phase 3]

View source ↗

Summary

Pilot study update for the Navigator Continuous Glucose Monitor in insulin-dependent diabetes. The Phase 2/3 trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Navigator Continuous Glucose Monitor

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Diabetes Mellitus, Insulin-Dependent | Phase 2, Phase 3 | Status: COMPLETED